SCHEMBL21912124

SCHEMBL21912124

C=CC[C@@H](CCCC)COc1nc(CC)c(CCC)c(N(CCC)CCC)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25020009 0.88 — —
SCHEMBL21895589 0.77 — —
SCHEMBL21912198 0.76 CRHR1 (0.34) —
SCHEMBL21846275 0.72 — —
SCHEMBL21895575 0.68 — —
SCHEMBL25019821 0.67 CRHR1 (0.30) —
SCHEMBL25021680 0.66 CRHR1 (0.35) —
SCHEMBL21846218 0.65 HRH3 (0.35) —
SCHEMBL21895740 0.64 ALDH1A1 (0.41) —
SCHEMBL21846280 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055755-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback